تقرير تحليل حجم السوق العالمية لأجهزة قياس الجلوكوز غير الجراحية، وحصتها السوقية، واتجاهاتها - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL NON-INVASIVE GLUCOSE METER MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL NON-INVASIVE GLUCOSE METER MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 SALES VALUE AND VOLUME

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL NON-INVASIVE GLUCOSE METER MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 VALUE CHAIN ANALYSIS

15 HEALTHCARE ECONOMY

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.1 ECONOMIC DEVELOPMENT

16 MANUAFCTURING AND R&D ANALYSIS

16.1 R&D ANALYSIS

16.2 BLOOD-SUGAR DETECTION VIA MONITORING

16.2.1 ACETONE CONTENTS IN BREATH

16.2.2 KETONE CONTENTS IN BREATH

16.2.3 OTHERS

16.3 MANUFACTURING PROCESS NONINVASIVE GLUCOMETERS

16.3.1 ACETONE CONTENTS IN BREATH

16.3.2 KETONE CONTENTS IN BREATH

16.3.3 OTHERS

17 EPIDEMIOLOGY

17.1 PREVALENCE AND INCIDENCE OF DIABETES, BY COUNTRY

17.2 PREVALENCE AND INCIDENCE OF DIABETES, BY AGE GROUP

18 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY PRODUCT TYPE

18.1 OVERVIEW

18.2 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

18.2.1 BY TYPE

18.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

18.2.1.1.1. MONITORING PATCHES

18.2.1.1.1.1 FABRIC PATCHES

18.2.1.1.1.2 OTHERS

18.2.1.1.2. CONTINUOUS MONITORING SENSORS

18.2.1.1.3. SMART LENSES

18.2.1.1.4. SMART WATCHES

18.2.1.1.5. OTHERS

18.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

18.2.1.2.1. TABLE TOP

18.2.1.2.2. HANDHELD

18.2.1.2.3. OTHERS

18.2.2 BY TECHNOLOGY

18.2.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)

18.2.2.2. POLARIZED OPTICAL ROTATION

18.2.2.3. RAMAN SPECTROSCOPY

18.2.2.4. FLUORESCENCE

18.2.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)

18.2.2.6. OTHERS

18.3 NONINVASIVE FLUID SAMPLING (NIFS-GM)

18.3.1 BY TYPE

18.3.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

18.3.1.1.1. MONITORING PATCHES

18.3.1.1.1.1 FABRIC PATCHES

18.3.1.1.1.2 OTHERS

18.3.1.1.2. CONTINUOUS MONITORING SENSORS

18.3.1.1.3. SMART LENSES

18.3.1.1.4. SMART WATCHES

18.3.1.1.5. OTHERS

18.3.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

18.3.1.2.1. TABLE TOP

18.3.1.2.2. HANDHELD

18.3.1.2.3. OTHERS

18.3.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL

18.3.1.3.1. SWNT-CS-GNP

18.3.1.3.2. PTB-GOX

18.3.1.3.3. NANO-GOLD

18.3.2 BY TECHNOLOGY

18.3.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING

18.3.2.2. TEAR-BASED GLUCOSE MONITORING

18.3.2.3. SWEAT-BASED GLUCOSE MONITORING

18.3.2.4. ISF-BASED GLUCOSE MONITORING

18.3.2.5. OTHERS

18.4 OTHERS

19 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY SITE

19.1 OVERVIEW

19.2 ARM/ WRIST

19.2.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

19.2.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

19.2.3 OTHERS

19.3 EAR LOBE

19.3.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

19.3.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

19.3.3 OTHERS

19.4 FOREFINGER AND THUMB

19.4.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

19.4.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

19.4.3 OTHERS

19.5 CORNEA/ EYE LID

19.5.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

19.5.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

19.5.3 OTHERS

19.6 OTHERS

20 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY APPLICATION

20.1 OVERVIEW

20.2 INTENSIVE INSULIN THERAPY

20.2.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

20.2.1.1. BY TYPE

20.2.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.2.1.1.1.1 MONITORING PATCHES

20.2.1.1.1.1.1. FABRIC PATCHES

20.2.1.1.1.1.2. OTHERS

20.2.1.1.1.2 CONTINUOUS MONITORING SENSORS

20.2.1.1.1.3 SMART LENSES

20.2.1.1.1.4 SMART WATCHES

20.2.1.1.1.5 OTHERS

20.2.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.2.1.1.2.1 TABLE TOP

20.2.1.1.2.2 HANDHELD

20.2.1.1.2.3 OTHERS

20.2.1.2. BY TECHNOLOGY

20.2.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)

20.2.1.2.2. POLARIZED OPTICAL ROTATION

20.2.1.2.3. RAMAN SPECTROSCOPY

20.2.1.2.4. FLUORESCENCE

20.2.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)

20.2.1.2.6. OTHERS

20.2.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

20.2.2.1. BY TYPE

20.2.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.2.2.1.1.1 MONITORING PATCHES

20.2.2.1.1.1.1. FABRIC PATCHES

20.2.2.1.1.1.2. OTHERS

20.2.2.1.1.2 CONTINUOUS MONITORING SENSORS

20.2.2.1.1.3 SMART LENSES

20.2.2.1.1.4 SMART WATCHES

20.2.2.1.1.5 OTHERS

20.2.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.2.2.1.2.1 TABLE TOP

20.2.2.1.2.2 HANDHELD

20.2.2.1.2.3 OTHERS

20.2.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL

20.2.2.1.3.1 SWNT-CS-GNP

20.2.2.1.3.2 PTB-GOX

20.2.2.1.3.3 NANO-GOLD

20.2.2.2. BY TECHNOLOGY

20.2.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING

20.2.2.2.2. TEAR-BASED GLUCOSE MONITORING

20.2.2.2.3. SWEAT-BASED GLUCOSE MONITORING

20.2.2.2.4. ISF-BASED GLUCOSE MONITORING

20.2.2.2.5. OTHERS

20.2.3 OTHERS

20.3 HYPOGLYCEMIA

20.3.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

20.3.1.1. BY TYPE

20.3.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.3.1.1.1.1 MONITORING PATCHES

20.3.1.1.1.1.1. FABRIC PATCHES

20.3.1.1.1.1.2. OTHERS

20.3.1.1.1.2 CONTINUOUS MONITORING SENSORS

20.3.1.1.1.3 SMART LENSES

20.3.1.1.1.4 SMART WATCHES

20.3.1.1.1.5 OTHERS

20.3.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.3.1.1.2.1 TABLE TOP

20.3.1.1.2.2 HANDHELD

20.3.1.1.2.3 OTHERS

20.3.1.2. BY TECHNOLOGY

20.3.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)

20.3.1.2.2. POLARIZED OPTICAL ROTATION

20.3.1.2.3. RAMAN SPECTROSCOPY

20.3.1.2.4. FLUORESCENCE

20.3.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)

20.3.1.2.6. OTHERS

20.3.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

20.3.2.1. BY TYPE

20.3.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.3.2.1.1.1 MONITORING PATCHES

20.3.2.1.1.1.1. FABRIC PATCHES

20.3.2.1.1.1.2. OTHERS

20.3.2.1.1.2 CONTINUOUS MONITORING SENSORS

20.3.2.1.1.3 SMART LENSES

20.3.2.1.1.4 SMART WATCHES

20.3.2.1.1.5 OTHERS

20.3.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.3.2.1.2.1 TABLE TOP

20.3.2.1.2.2 HANDHELD

20.3.2.1.2.3 OTHERS

20.3.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL

20.3.2.1.3.1 SWNT-CS-GNP

20.3.2.1.3.2 PTB-GOX

20.3.2.1.3.3 NANO-GOLD

20.3.2.2. BY TECHNOLOGY

20.3.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING

20.3.2.2.2. TEAR-BASED GLUCOSE MONITORING

20.3.2.2.3. SWEAT-BASED GLUCOSE MONITORING

20.3.2.2.4. ISF-BASED GLUCOSE MONITORING

20.3.2.2.5. OTHERS

20.3.3 OTHERS

20.4 DIABETIC FOOT ULCER TRACKING

20.4.1 NONINVASIVE OPTICAL GLUCOSE MONITORING (NIO-GM)

20.4.1.1. BY TYPE

20.4.1.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.4.1.1.1.1 MONITORING PATCHES

20.4.1.1.1.1.1. FABRIC PATCHES

20.4.1.1.1.1.2. OTHERS

20.4.1.1.1.2 CONTINUOUS MONITORING SENSORS

20.4.1.1.1.3 SMART LENSES

20.4.1.1.1.4 SMART WATCHES

20.4.1.1.1.5 OTHERS

20.4.1.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.4.1.1.2.1 TABLE TOP

20.4.1.1.2.2 HANDHELD

20.4.1.1.2.3 OTHERS

20.4.1.2. BY TECHNOLOGY

20.4.1.2.1. NEAR-INFRARED REFLECTANCE SPECTROSCOPY (NIRS)

20.4.1.2.2. POLARIZED OPTICAL ROTATION

20.4.1.2.3. RAMAN SPECTROSCOPY

20.4.1.2.4. FLUORESCENCE

20.4.1.2.5. OPTICAL COHERENCE TOMOGRAPHY (OCT)

20.4.1.2.6. OTHERS

20.4.2 NONINVASIVE FLUID SAMPLING (NIFS-GM)

20.4.2.1. BY TYPE

20.4.2.1.1. WEARABLE GLUCOSE MONITORING SYSTEMS

20.4.2.1.1.1 MONITORING PATCHES

20.4.2.1.1.1.1. FABRIC PATCHES

20.4.2.1.1.1.2. OTHERS

20.4.2.1.1.2 CONTINUOUS MONITORING SENSORS

20.4.2.1.1.3 SMART LENSES

20.4.2.1.1.4 SMART WATCHES

20.4.2.1.1.5 OTHERS

20.4.2.1.2. NON-WEARABLE GLUCOSE MONITORING SYSTEMS

20.4.2.1.2.1 TABLE TOP

20.4.2.1.2.2 HANDHELD

20.4.2.1.2.3 OTHERS

20.4.2.1.3. NON-WEARABLE DEVICE ELECTRODE MATERIAL

20.4.2.1.3.1 SWNT-CS-GNP

20.4.2.1.3.2 PTB-GOX

20.4.2.1.3.3 NANO-GOLD

20.4.2.2. BY TECHNOLOGY

20.4.2.2.1. SALIVA-BASED AND BREATH ACETONE GLUCOSE MONITORING

20.4.2.2.2. TEAR-BASED GLUCOSE MONITORING

20.4.2.2.3. SWEAT-BASED GLUCOSE MONITORING

20.4.2.2.4. ISF-BASED GLUCOSE MONITORING

20.4.2.2.5. OTHERS

20.4.3 OTHERS

20.5 OTHERS

21 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY END USER

21.1 OVERVIEW

21.2 HOSPITALS

21.2.1 PUBLIC

21.2.2 PRIVATE

21.3 SPECIALITY CLINICS

21.4 DIAGNOSTIC CENTRES

21.5 HOME CARE SETTINGS

21.6 AMBULATORY SURGICAL CENTERS

21.7 ACADEMIC & RESEARCH INSTITUTES

21.8 OTHERS

22 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY DISTRIBUTION CHANNEL

22.1 OVERVIEW

22.2 DIRECT TENDER

22.3 RETAIL SALES

22.3.1 ONLINE SALES

22.3.2 OFFLINE SALES

22.4 OTHERS

23 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, BY GEOGRAPHY

GLOBAL NON-INVASIVE GLUCOSE METER MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

23.1 NORTH AMERICA

23.1.1 U.S.

23.1.2 CANADA

23.1.3 MEXICO

23.2 EUROPE

23.2.1 GERMANY

23.2.2 FRANCE

23.2.3 U.K.

23.2.4 ITALY

23.2.5 SPAIN

23.2.6 RUSSIA

23.2.7 TURKEY

23.2.8 BELGIUM

23.2.9 NETHERLANDS

23.2.10 SWITZERLAND

23.2.11 REST OF EUROPE

23.3 ASIA-PACIFIC

23.3.1 JAPAN

23.3.2 CHINA

23.3.3 SOUTH KOREA

23.3.4 INDIA

23.3.5 AUSTRALIA

23.3.6 SINGAPORE

23.3.7 THAILAND

23.3.8 MALAYSIA

23.3.9 INDONESIA

23.3.10 PHILIPPINES

23.3.11 REST OF ASIA-PACIFIC

23.4 SOUTH AMERICA

23.4.1 BRAZIL

23.4.2 ARGENTINA

23.4.3 REST OF SOUTH AMERICA

23.5 MIDDLE EAST AND AFRICA

23.5.1 SOUTH AFRICA

23.5.2 SAUDI ARABIA

23.5.3 UAE

23.5.4 EGYPT

23.5.5 ISRAEL

23.5.6 REST OF MIDDLE EAST AND AFRICA

23.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

24 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, SWOT AND DBMR ANALYSIS

25 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, COMPANY LANDSCAPE

25.1 COMPANY SHARE ANALYSIS: GLOBAL

25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

25.3 COMPANY SHARE ANALYSIS: EUROPE

25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

25.5 MERGERS & ACQUISITIONS

25.6 NEW PRODUCT DEVELOPMENT & APPROVALS

25.7 EXPANSIONS

25.8 REGULATORY CHANGES

25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

26 GLOBAL NON-INVASIVE GLUCOSE METER MARKET, COMPANY PROFILE

26.1 ABBOTT

26.1.1 COMPANY OVERVIEW

26.1.2 REVENUE ANALYSIS

26.1.3 GEOGRAPHIC PRESENCE

26.1.4 PRODUCT PORTFOLIO

26.1.5 RECENT DEVELOPMENTS

26.2 ASCENSIA DIABETES CARE HOLDINGS AG (PHC HOLDINGS CORPORATION)

26.2.1 COMPANY OVERVIEW

26.2.2 REVENUE ANALYSIS

26.2.3 GEOGRAPHIC PRESENCE

26.2.4 PRODUCT PORTFOLIO

26.2.5 RECENT DEVELOPMENTS

26.3 DEXCOM, INC.

26.3.1 COMPANY OVERVIEW

26.3.2 REVENUE ANALYSIS

26.3.3 GEOGRAPHIC PRESENCE

26.3.4 PRODUCT PORTFOLIO

26.3.5 RECENT DEVELOPMENTS

26.4 MEDTRONIC

26.4.1 COMPANY OVERVIEW

26.4.2 REVENUE ANALYSIS

26.4.3 GEOGRAPHIC PRESENCE

26.4.4 PRODUCT PORTFOLIO

26.4.5 RECENT DEVELOPMENTS

26.5 INTEGRITY APPLICATIONS

26.5.1 COMPANY OVERVIEW

26.5.2 REVENUE ANALYSIS

26.5.3 GEOGRAPHIC PRESENCE

26.5.4 PRODUCT PORTFOLIO

26.5.5 RECENT DEVELOPMENTS

26.6 DIAMONTECH AG

26.6.1 COMPANY OVERVIEW

26.6.2 REVENUE ANALYSIS

26.6.3 GEOGRAPHIC PRESENCE

26.6.4 PRODUCT PORTFOLIO

26.6.5 RECENT DEVELOPMENTS

26.7 CNOGA

26.7.1 COMPANY OVERVIEW

26.7.2 REVENUE ANALYSIS

26.7.3 GEOGRAPHIC PRESENCE

26.7.4 PRODUCT PORTFOLIO

26.7.5 RECENT DEVELOPMENTS

26.8 BOYDSENSE SAS

26.8.1 COMPANY OVERVIEW

26.8.2 REVENUE ANALYSIS

26.8.3 GEOGRAPHIC PRESENCE

26.8.4 PRODUCT PORTFOLIO

26.8.5 RECENT DEVELOPMENTS

26.9 META MATERIALS INC.

26.9.1 COMPANY OVERVIEW

26.9.2 REVENUE ANALYSIS

26.9.3 GEOGRAPHIC PRESENCE

26.9.4 PRODUCT PORTFOLIO

26.9.5 RECENT DEVELOPMENTS

26.1 OPTICOLOGY INC.

26.10.1 COMPANY OVERVIEW

26.10.2 REVENUE ANALYSIS

26.10.3 GEOGRAPHIC PRESENCE

26.10.4 PRODUCT PORTFOLIO

26.10.5 RECENT DEVELOPMENTS

26.11 HAGAR TECHNOLOGY

26.11.1 COMPANY OVERVIEW

26.11.2 REVENUE ANALYSIS

26.11.3 GEOGRAPHIC PRESENCE

26.11.4 PRODUCT PORTFOLIO

26.11.5 RECENT DEVELOPMENTS

26.12 NEMAURA

26.12.1 COMPANY OVERVIEW

26.12.2 REVENUE ANALYSIS

26.12.3 GEOGRAPHIC PRESENCE

26.12.4 PRODUCT PORTFOLIO

26.12.5 RECENT DEVELOPMENTS

26.13 KNOW LABS, INC.

26.13.1 COMPANY OVERVIEW

26.13.2 REVENUE ANALYSIS

26.13.3 GEOGRAPHIC PRESENCE

26.13.4 PRODUCT PORTFOLIO

26.13.5 RECENT DEVELOPMENTS

26.14 NOVIOSENSE

26.14.1 COMPANY OVERVIEW

26.14.2 REVENUE ANALYSIS

26.14.3 GEOGRAPHIC PRESENCE

26.14.4 PRODUCT PORTFOLIO

26.14.5 RECENT DEVELOPMENTS

26.15 LIFEPLUS

26.15.1 COMPANY OVERVIEW

26.15.2 REVENUE ANALYSIS

26.15.3 GEOGRAPHIC PRESENCE

26.15.4 PRODUCT PORTFOLIO

26.15.5 RECENT DEVELOPMENTS

26.16 AFON TECHNOLOGY

26.16.1 COMPANY OVERVIEW

26.16.2 REVENUE ANALYSIS

26.16.3 GEOGRAPHIC PRESENCE

26.16.4 PRODUCT PORTFOLIO

26.16.5 RECENT DEVELOPMENTS

26.17 OCCUITY

26.17.1 COMPANY OVERVIEW

26.17.2 REVENUE ANALYSIS

26.17.3 GEOGRAPHIC PRESENCE

26.17.4 PRODUCT PORTFOLIO

26.17.5 RECENT DEVELOPMENTS

26.18 ESER COMPANY

26.18.1 COMPANY OVERVIEW

26.18.2 REVENUE ANALYSIS

26.18.3 GEOGRAPHIC PRESENCE

26.18.4 PRODUCT PORTFOLIO

26.18.5 RECENT DEVELOPMENTS

26.19 ETOUCHUS PVT LTD.

26.19.1 COMPANY OVERVIEW

26.19.2 REVENUE ANALYSIS

26.19.3 GEOGRAPHIC PRESENCE

26.19.4 PRODUCT PORTFOLIO

26.19.5 RECENT DEVELOPMENTS

26.2 VIVALYF INNOVATIONS

26.20.1 COMPANY OVERVIEW

26.20.2 REVENUE ANALYSIS

26.20.3 GEOGRAPHIC PRESENCE

26.20.4 PRODUCT PORTFOLIO

26.20.5 RECENT DEVELOPMENTS

26.21 GLUCOACTIVE LTD.

26.21.1 COMPANY OVERVIEW

26.21.2 REVENUE ANALYSIS

26.21.3 GEOGRAPHIC PRESENCE

26.21.4 PRODUCT PORTFOLIO

26.21.5 RECENT DEVELOPMENTS

26.22 RSP SYSTEMS A/S

26.22.1 COMPANY OVERVIEW

26.22.2 REVENUE ANALYSIS

26.22.3 GEOGRAPHIC PRESENCE

26.22.4 PRODUCT PORTFOLIO

26.22.5 RECENT DEVELOPMENTS

26.23 AERBETIC

26.23.1 COMPANY OVERVIEW

26.23.2 REVENUE ANALYSIS

26.23.3 GEOGRAPHIC PRESENCE

26.23.4 PRODUCT PORTFOLIO

26.23.5 RECENT DEVELOPMENTS

26.24 SINOCARE

26.24.1 COMPANY OVERVIEW

26.24.2 REVENUE ANALYSIS

26.24.3 GEOGRAPHIC PRESENCE

26.24.4 PRODUCT PORTFOLIO

26.24.5 RECENT DEVELOPMENTS

26.25 IGLUCO TECH, S.L.

26.25.1 COMPANY OVERVIEW

26.25.2 REVENUE ANALYSIS

26.25.3 GEOGRAPHIC PRESENCE

26.25.4 PRODUCT PORTFOLIO

26.25.5 RECENT DEVELOPMENTS

*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS

27 CONCLUSION

28 QUESTIONNAIRE

29 ABOUT DATA BRIDGE MARKET RESEARCH